Related Experiment Video
Updated: Jan 27, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
A Nanosheet-Anchored Hydrogel System: An Injectable Platform for Herbs Polyphenols in Treating Ulcerative Colitis
Lu Wang1, Bingwen Zhou1, Jiale Chen2
1Jiangsu Clinical Innovation Center for Anorectal Diseases of T.C.M, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022, China.
None:
Natural polyphenols derived from medicinal herbs exhibit significant anti-inflammatory and tissue-repair properties, demonstrating considerable therapeutic potential for inflammatory injury diseases such as ulcerative colitis (UC). However, the development of sustained-release carriers compatible with polyphenols remains a critical challenge. In this study, we engineered a hydrogel system by integrating Cayratia japonica polyphenols with boric acid-modified manganese dioxide nanosheets (MNS) into a hyaluronic acid-dopamine (HA-DA) matrix for targeted UC therapy. The designed hydrogel exhibited a three-dimensional porous architecture and mucoadhesive characteristics, facilitating the sustained release of therapeutic components in the colonic microenvironment. In vitro studies demonstrated synergistic therapeutic effects, including oxygen generation, reactive oxygen species (ROS) scavenging, and controlled polyphenols release. In vivo assessments using murine colitis models revealed that the hydrogel significantly mitigated disease progression, as evidenced by attenuated body weight loss, reduced disease activity index (DAI) scores, and suppression of colon shortening. Histopathological and immunofluorescence analyses further confirmed the restoration of the intestinal epithelial barrier through upregulation of tight junction proteins (Claudin-1 and ZO-1) and modulation of macrophage polarization (M1-to-M2 phenotype transition). This multifunctional hydrogel platform represents a promising strategy for the in situ delivery of natural polyphenols, offering a potent and targeted approach for UC intervention.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
The Anchoring-and-Adjustment Heuristic
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
Anchoring Junctions

